Inventor · disambiguated record
Yan Chen
Also filed as: CHEN YAN · Chen yan-yi
50 granted patents·30 pending applications·853 citations·filing 1993–2024
98Inventor score
Files withX BODY INC16JUNO THERAPEUTICS INC10ELPIS BIOPHARMACEUTICALS9TAIWAN SEMICONDUCTOR MFG CO LTD9CHEN YAN5
Top patents by PatentIndex Score
80 records- 0198US8226611B2Anti-IL-6 antibodies, compositions, methods and usesCHEN YAN·Filed 2011·Granted Jul 24, 2012·64 cites·8 claims
- 0298US7560112B2Anti-il-6 antibodies, compositions, methods and usesAPPLIED MOLECULAR EVOLUTION·Filed 2006·Granted Jul 14, 2009·84 cites·16 claims
- 0397US8623362B2Anti-IL-6 antibodiesCHEN YAN·Filed 2012·Granted Jan 7, 2014·44 cites·11 claims
- 0497US8067003B2Methods of treating conditions using anti-IL-6 antibodiesCHEN YAN·Filed 2010·Granted Nov 29, 2011·46 cites·12 claims
- 0597US7915388B2Interleukin-13 binding proteinsABBOTT LAB·Filed 2007·Granted Mar 29, 2011·96 cites·41 claims
- 0697US7833755B2Anti-IL-6 antibody nucleic acid molecules and methodsCHEN YAN·Filed 2009·Granted Nov 16, 2010·50 cites·12 claims
- 0793US10889652B2Antibodies and chimeric antigen receptors specific for ROR1JUNO THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·9 cites·29 claims
- 0892US10533055B2Antibodies and chimeric antigen receptors specific for CD19JUNO THERAPEUTICS INC·Filed 2015·Granted Jan 14, 2020·16 cites·48 claims
- 0992US9592293B2Interleukin-13 binding proteinsABBVIE INC·Filed 2013·Granted Mar 14, 2017·18 cites·13 claims
- 1091US11066475B2Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotidesJUNO THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·10 cites·23 claims
- 1189US11623961B2Antibodies and chimeric antigen receptors specific for B-cell maturation antigenJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·7 cites·35 claims
- 1288US9880160B2Antibody screening methodsCHEN YAN·Filed 2012·Granted Jan 30, 2018·5 cites·15 claims
- 1388US5679512AMethod for introducing defined sequences at the 3'end of polynucleotidesBEHRINGWERKE AG·Filed 1993·Granted Oct 21, 1997·160 cites·39 claims
- 1487US11344621B2Interleukin-13 binding proteinsABBVIE INC·Filed 2018·Granted May 31, 2022·2 cites·35 claims
- 1587US5683879AMethods for producing a single stranded polydeoxynucleotide having two different defined sequences and kitsBEHRINGWERKE AG·Filed 1995·Granted Nov 4, 1997·122 cites·12 claims
- 1686US11919970B2Antibodies and chimeric antigen receptors specific for ROR1JUNO THERAPEUTICS INC·Filed 2020·Granted Mar 5, 2024·1 cites·40 claims
- 1786US10086076B2Interleukin-13 binding proteinsABBVIE INC·Filed 2017·Granted Oct 2, 2018·4 cites·11 claims
- 1883US2025122276A1Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 1982US9134304B2Protein screening methodsWAGNER RICHARD W·Filed 2011·Granted Sep 15, 2015·4 cites·29 claims
- 2081US12065488B2Anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2021·Granted Aug 20, 2024·0 cites·4 claims
- 2180US11512127B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesVIELA BIO INC·Filed 2019·Granted Nov 29, 2022·2 cites·21 claims
- 2279US6030774AMethod for introducing defined sequences at the 3' end of polynucleotidesBEHRING DIAGNOSTICS GMBH·Filed 1995·Granted Feb 29, 2000·63 cites·20 claims
- 2378US12209123B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2022·Granted Jan 28, 2025·0 cites·19 claims
- 2478US8604177B2Interleukin-13 binding proteinsWU CHENGBIN·Filed 2011·Granted Dec 10, 2013·3 cites·30 claims
- 2577US9416179B2PDGF receptor beta binding polypeptidesX-BODY INC·Filed 2012·Granted Aug 16, 2016·2 cites·26 claims
- 2677US6632673B1Directing the ratio of B2:B1 avermectins in Streptomyces avermitilis host cellsPFIZER·Filed 2000·Granted Oct 14, 2003·4 cites·42 claims
- 2776US2023074705A1Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopesX BODY INC·Filed 2022·Application pending·0 cites
- 2876US2024018256A1Antibodies and chimeric antigen receptors specific for cd19JUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2974US11827714B2Antibodies and chimeric antigen receptors specific for CD19JUNO THERAPEUTICS INC·Filed 2019·Granted Nov 28, 2023·0 cites·31 claims
- 3074US11268090B2X-display complexes for protein screening methodsX BODY INC·Filed 2019·Granted Mar 8, 2022·0 cites·20 claims
- 3174US11180549B2Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Nov 23, 2021·0 cites·12 claims
- 3274US9803193B2Protein screening methodsX-BODY INC·Filed 2015·Granted Oct 31, 2017·1 cites·44 claims
- 3373US2022089748A1Pdgf receptor beta binding polypeptidesX BODY INC·Filed 2021·Application pending·0 cites
- 3471US11414784B2Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopesX BODY INC·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 3571US7388085B2Streptomyces avermitilis gene directing the ratio of B2:B1 avermectinsPFIZER·Filed 2003·Granted Jun 17, 2008·2 cites·8 claims
- 3670US11136398B2PDGF receptor beta binding polypeptidesX BODY INC·Filed 2020·Granted Oct 5, 2021·0 cites·24 claims
- 3770US7365154B2Peptides antagonistic to an anti-angiogenic antibody and uses thereforCENTOCOR INC·Filed 2004·Granted Apr 29, 2008·2 cites·3 claims
- 3869US11629434B2Antibody screening methodsX BODY INC·Filed 2020·Granted Apr 18, 2023·0 cites·10 claims
- 3969US2023365699A1Antibodies and chimeric antigen receptors specific for b-cell maturation antigenJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4067US9340613B2Anti-IL-6 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted May 17, 2016·0 cites·9 claims
- 4166US10519438B2Protein screening methodsX BODY INC·Filed 2017·Granted Dec 31, 2019·0 cites·8 claims
- 4266US2025326813A1Engineered interleukin-2 receptor beta reduced-binding agonistELPIS BIOPHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 4365US10202462B2Bi-specific antigen-binding polypeptidesX BODY INC·Filed 2015·Granted Feb 12, 2019·1 cites·9 claims
- 4465US2017253651A1Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 AntibodyJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 4564US11339388B2Methods and compositions for generation of binding agents against cell surface antigensX BODY INC·Filed 2019·Granted May 24, 2022·0 cites·19 claims
- 4664US10677787B2Antibody screening methodsX BODY INC·Filed 2017·Granted Jun 9, 2020·0 cites·13 claims
- 4764US9631016B2Pen-injector device containing anti-IL-6 antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Apr 25, 2017·0 cites·13 claims
- 4864US2025382340A1Dna constructs for improved t cell immunotherapyUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 4963US10519436B2Methods and compositions for generation of binding agents against cell surface antigensX BODY INC·Filed 2014·Granted Dec 31, 2019·0 cites·17 claims
- 5063US5605796AMethod for preventing amplification of nucleic acid contaminants in amplification mixtures using nuclease-receptor conjugatesBEHRINGWERKE AG·Filed 1994·Granted Feb 25, 1997·31 cites·45 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yan Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →